share_log

Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy

Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy

sangamo therapeutics获得FDA批准的IND申请,用于治疗特发性小纤维神经病的St-503。
Benzinga ·  11/20 05:16

Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy

Sangamo therapeutics 获得FDA批准,允许针对特发性小纤维神经病的St-503进行IND申请。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发